Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SINTILIMAB vs SIPONIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SINTILIMAB vs SIPONIMOD: Safety Overview

Metric SINTILIMAB SIPONIMOD
Total FAERS Reports 652 8,581
Deaths Reported 61 196
Death Rate 9.4% 2.3%
Hospitalizations 225 1,396
Average Patient Age 57.6 yrs 53.8 yrs
% Female Patients 35.0% 74.4%
FDA Approval Date N/A Apr 22, 2025
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription